Brussels, 28 June 2023

Today, EuropaBio’s General Assembly confirmed the appointment of Dr. Sarah Reisinger as the new Chair of the association. Sarah Reisinger is the Chief Science & Research Officer at dsm-firmenich.

Commenting on her appointment, Sarah Reisinger highlighted: "I feel privileged to take on the Chair of EuropaBio. Biotechnology is at the heart of my career as a scientist. I am passionate about the benefits and breakthroughs it brings to areas such as healthcare, nutrition, personal care, and the broader bioeconomy, enabling renewable and sustainable solutions for the world. I’m looking forward to further championing the role of biotechnology for healthcare and industrial products and the critical role of biomanufacturing for Europe’s green transition. Innovation is vital to unlock the potential of biotechnology for the sustainable future of the planet and our quality of life. There’s so much we can achieve together to secure Europe’s role as a global leader!"

Dr Claire Skentelbery, Director General of EuropaBio added "We are delighted to welcome Sarah as the new Chair of EuropaBio, representing the future of next generation sustainable industry in Europe through the newly created dsm-firmenich. This comes at a pivotal time for European legislation in biotechnology and EuropaBio builds on the voice of its members to ensure that it leads the way for a modern Europe in the world."

Dr. Sarah Reisinger will take on the new role with immediate effect for a two-year mandate.